NETHERLANDS - BioGeneration and CAPE back FlexGen
BioGeneration Ventures and Crédit Agricole Private Equity have participated in a new round of financing for Dutch biotech company FlexGen.
Leiden-based FlexGen was founded in 2004 and is the developer of FlexArrayer, a proprietary instrument that provides unprecedented freedom in the production of custom microarrays. FlexGen is collaborating with several leading scientific and industrial customers and partners to develop innovative solutions for next generation sequencing, biomarker validation and other application areas.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








